ACUTE MYELOID LEUKEMIA WITH RUNX1 MUTATIONS CONSTITUTE A DISTINCT ENTITY ASSOCIATED WITH CHARACTERISTIC CLINICAL AND GENETIC FEATURES AND POOR OUTCOME. A STUDY OF THE AML STUDY GROUP (AMLSG)

被引：0

作者：

Gaidzik, V. I. ^{[1
]}

Teleanu, V. ^{[1
]}

Schlenk, R. F. ^{[1
]}

Spaeth, D. ^{[1
]}

Paschka, P. ^{[1
]}

Hahn, J. ^{[1
]}

Koehne, C. H. ^{[2
]}

Horst, H. A. ^{[3
]}

Schmidt-Wolf, I. ^{[4
]}

Held, G. ^{[5
]}

Kuendgen, A. ^{[6
]}

Ringhoffer, M. ^{[7
]}

Goetze, K. ^{[8
]}

Rummel, M. ^{[9
]}

Wulf, G. ^{[10
]}

Nachbaur, D. ^{[11
]}

Fiedler, W. ^{[12
]}

Corbacioglu, A. ^{[1
]}

Bullinger, L. ^{[1
]}

Schlegelberger, B. ^{[13
]}

Thol, F. ^{[13
]}

Heuser, M. ^{[13
]}

Ganser, A. ^{[13
]}

Doehner, K. ^{[1
]}

Doehner, H. ^{[1
]}

机构：

[1] Univ Ulm Klinikum, Ulm, Germany

[2] Klinikum Oldenburg GmbH, Oldenburg, Germany

[3] Univ Klinikum Schleswig Holstein, Kiel, Germany

[4] Univ Klinikum Bonn, Bonn, Germany

[5] Univ Klinikum Saarlandes, Homburg, Germany

[6] Univ Klinikum Dusseldorf, Dusseldorf, Germany

[7] Stadt Klinikum Karlsruhe GmbH, Karlsruhe, Germany

[8] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany

[9] Univ Giessen Klinikum, Giessen, Germany

[10] Univ Klinikum Gottingen, Gottingen, Germany

[11] Univ Klinikum Innsbruck, Innsbruck, Austria

[12] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[13] Hannover Med Sch, D-30623 Hannover, Germany

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

S721

引用

页码：257 / 257

页数：1

共 50 条

[1] RUNX1 Mutations in Acute Myeloid Leukemia (AML): Correlation with Distinct Cytogenetic Subgroups and Clinical Outcome. Results of the AML Study Group (AMLSG)
Gaidzik, Verena I.
Schlenk, Richard F.
Wittke, Kerstin
Becker, Annegret
Zimmermann, Andreas
Schlegelberger, Brigitte
Ganser, Arnold
Spaeth, Daniela
Doehner, Hartmut
Doehner, Konstanze
[J]. BLOOD, 2008, 112 (11) : 59 - 59
[2] RUNX1 MUTATIONS FORM A DISTINCT MOLECULAR SUBGROUP IN ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML STUDY GROUP (AMLSG)
Gaidzik, V.
Bullinger, L.
Schlenk, R.
Zimmermann, A.
Roeck, J.
Schlegelberger, B.
Krauter, J.
Ganser, A.
Spaeth, D.
Doehner, H.
Doehner, K.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 483 - 483
[3] RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
Gaidzik, Verena I.
Bullinger, Lars
Schlenk, Richard F.
Zimmermann, Andreas S.
Roeck, Juergen
Paschka, Peter
Corbacioglu, Andrea
Krauter, Juergen
Schlegelberger, Brigitte
Ganser, Arnold
Spaeth, Daniela
Kuendgen, Andrea
Schmidt-Wolf, Ingo G. H.
Goetze, Katharina
Nachbaur, David
Pfreundschuh, Michael
Horst, Heinz A.
Doehner, Hartmut
Doehner, Konstanze
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) : 1364 - 1372
[4] RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
V I Gaidzik
V Teleanu
E Papaemmanuil
D Weber
P Paschka
J Hahn
T Wallrabenstein
B Kolbinger
C H Köhne
H A Horst
P Brossart
G Held
A Kündgen
M Ringhoffer
K Götze
M Rummel
M Gerstung
P Campbell
J M Kraus
H A Kestler
F Thol
M Heuser
B Schlegelberger
A Ganser
L Bullinger
R F Schlenk
K Döhner
H Döhner
[J]. Leukemia, 2016, 30 : 2160 - 2168
[5] RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis
Yamato, Genki
Shiba, Norio
Yoshida, Kenichi
Hara, Yusuke
Shiraishi, Yuichi
Ohki, Kentaro
Okubo, Jun
Park, Myoung-ja
Sotomatsu, Manabu
Arakawa, Hirokazu
Kiyokawa, Nobutaka
Tomizawa, Daisuke
Adachi, Souichi
Taga, Takashi
Horibe, Keizo
Miyano, Satoru
Ogawa, Seishi
Hayashi, Yasuhide
[J]. BLOOD, 2018, 131 (20) : 2266 - 2270
[6] De Novo Acute Myeloid Leukemia (AML) with RUNX1 Mutations Shows Characteristic Clinicopathologic Features
Quesada, Andres
Luthra, Rajyalakshmi
Patel, Keyur P.
Singh, Rajesh
Routbort, Mark
Loghavi, Sanam
Khoury, Joseph D.
Medeiros, Jeffrey
Bueso-Ramos, Carlos E.
Kanagal-Shamanna, Rashmi
[J]. MODERN PATHOLOGY, 2016, 29 : 371A - 371A
[7] De Novo Acute Myeloid Leukemia (AML) with RUNX1 Mutations Shows Characteristic Clinicopathologic Features
Quesada, Andres
Luthra, Rajyalakshmi
Patel, Keyur P.
Singh, Rajesh
Routbort, Mark
Loghavi, Sanam
Khoury, Joseph D.
Medeiros, Jeffrey
Bueso-Ramos, Carlos E.
Kanagal-Shamanna, Rashmi
[J]. LABORATORY INVESTIGATION, 2016, 96 : 371A - 371A
[8] Erratum: RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
V I Gaidzik
V Teleanu
E Papaemmanuil
D Weber
P Paschka
J Hahn
T Wallrabenstein
B Kolbinger
C H Köhne
H A Horst
P Brossart
G Held
A Kündgen
M Ringhoffer
K Götze
M Rummel
M Gerstung
P Campbell
J M Kraus
H A Kestler
F Thol
M Heuser
B Schlegelberger
A Ganser
L Bullinger
R F Schlenk
K Döhner
H Döhner
[J]. Leukemia, 2016, 30 : 2282 - 2282
[9] RUNX1 together with DAT mutations predicted poor outcome in acute myeloid leukemia
Xiao, Jinyan
Xie, Jundan
Zhou, Biqi
Liu, Yujie
Lu, Jing
Jiang, Airui
Yao, Hong
Qiu, Qiaocheng
Ding, Zixuan
Xue, Shengli
Tang, Xiaowen
Qiu, Huiying
Chen, Suning
Shen, Hongjie
Wu, Depei
Xu, Yang
[J]. LEUKEMIA & LYMPHOMA, 2023, 64 (05) : 951 - 961
[10] CLINICAL IMPACT OF TET2 MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS HARBORING CEBPA MUTATIONS: A STUDY OF THE AML STUDY GROUP (AMLSG)
Theis, F.
Corbacioglu, A.
Gaidzik, V. I.
Paschka, P.
Weber, D.
Bullinger, L.
Schlegelberger, B.
Goehring, G.
Koehne, C. -H.
Kraemer, D.
Germing, U.
Brossart, P.
Horst, H. -A.
Haase, D.
Goetze, K.
Ringhoffer, M.
Fiedler, W.
Nachbaur, D.
Kindler, T.
Held, G.
Luebert, M.
Wattad, M.
Salih, H. R.
Krauter, J.
Heuser, M.
Thol, F.
Ganser, A.
Doehner, H.
Schlenk, R. F.
Doehner, K.
[J]. HAEMATOLOGICA, 2017, 102 : 203 - 204

← 1 2 3 4 5 →